Ranibizumab (Anti-VEGFA)

Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.

• Supplier: Selleck Chemicals
• Product #: A2305
• Sku #: A2305-1mg